Technical Guide to Angiotensin I/II (1-5) for RAS Research Workflows

What This Product Solves

Angiotensin I/II (1-5), a pentapeptide with the sequence Asp-Arg-Val-Tyr-Ile, addresses the need for a standardized peptide fragment to model specific components of the renin-angiotensin system (RAS). Its defined structure enables focused investigations into blood pressure regulation and aldosterone release pathways, both critical in cardiovascular and renal physiology. The product is particularly suitable for workflows requiring precise control over peptide dosing and reproducibility, as is necessary for mechanistic studies in hypertension research and RAS signaling (product_spec).

This peptide should not be used in unrelated peptide signaling or non-RAS contexts, as its activity and solubility profile are tailored specifically for cardiovascular and renal research. For further practical usage context and peer guidance, see "Technical Use of Angiotensin I/II (1-5) in RAS Research", which details the compound’s defined utility in RAS workflows.

Protocol Parameters

• Solubility screening | DMSO ≥66.5 mg/mL, Ethanol ≥69.5 mg/mL | Required for assay setup in cardiovascular and renal models | Ensures accurate stock preparation and stability for Asp-Arg-Val-Tyr-Ile peptide dosing | product_spec
• Storage condition | -20°C | Long-term and short-term storage for peptide stocks | Maintains peptide integrity and prevents degradation between experimental runs | product_spec
• Assay restriction | Cardiovascular and renal RAS workflows only | Should not be used in non-RAS or unrelated peptide signaling assays | Supports controlled modeling of blood pressure regulation and aldosterone release only in validated biological systems | workflow_recommendation (Practical Guide to Angiotensin I/II (1-5) in Hypertension Research)

Workflow Setup and QC Checklist

• Stock Preparation: Dissolve Angiotensin I/II (1-5) in DMSO or ethanol according to solubility limits specified above. Avoid water due to insolubility (product_spec).
• Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles and maintain peptide activity.
• Quality Control: Confirm peptide identity and purity by mass spectrometry or HPLC if available, especially when working with highly sensitive RAS signaling assays.
• Assay Validation: Use only in validated cardiovascular or renal models. Ensure the presence of relevant RAS components (e.g., renin, ACE, aldosterone pathway markers).
• Documentation: Record batch number, solvent used, and storage conditions for each experimental run to support reproducibility.

Common Failure Modes and Fixes

• Incomplete Dissolution: If peptide does not dissolve fully in DMSO or ethanol, gently warm the solution to room temperature and vortex. Do not attempt to dissolve in water.
• Peptide Degradation: Avoid repeated freeze-thaw cycles by preparing single-use aliquots. Discard any thawed aliquots not used immediately.
• Off-target Effects: Restrict use to cardiovascular and renal models. Use appropriate negative controls to confirm specificity in blood pressure regulation peptide studies.
• Solvent Interference: When using DMSO or ethanol as vehicle controls, maintain solvent concentration below cytotoxic thresholds for the biological system in use.

Scope and Limitations

Angiotensin I/II (1-5) is optimized for research focused on the renin-angiotensin system, specifically for studies involving blood pressure regulation and aldosterone release stimulation in cardiovascular and renal contexts. The compound's insolubility in water and defined activity as a vasoconstrictor peptide fragment limit its application to these domains (Technical Use of Angiotensin I/II (1-5) in RAS Research Workflows). It is not suitable for workflows investigating unrelated peptide signaling pathways, broad endocrine studies, or non-RAS biological models. Application outside these boundaries may yield unreliable or uninterpretable results.

Conclusion

For researchers modeling the renin-angiotensin system, Angiotensin I/II (1-5) provides a well-defined Asp-Arg-Val-Tyr-Ile peptide fragment, enabling reproducible and controlled studies of blood pressure and aldosterone signaling. Strict adherence to solubility, storage, and workflow parameters is essential for reliable results. Use is recommended only within clearly validated cardiovascular and renal research protocols to ensure specificity and data integrity.